Location: Berlin, Germany
Start Date: Sep 09, 2026
End Date: Sep 11, 2026
Type of Event: Scientific Conferences
Attendees:

Join us in-person in Berlin, Germany for the 14th GSCN Conference, which we are supporting as a Bronze Sponsor. Learn more about our involvement in the event below.

Evotec at 14th GSCN Conference 2026

Oral Presentations

Off-The-Shelf Immune-Shielded iPSC-Derived CAR γδ T Cells as Novel Cell Therapy to Treat Hepatocellular Carcinoma  

Presenter: Stephanie Sontag, Senior Research Scientist, iPSC Cell Therapy
Date and Time: Thursday, 10 September, 2026, 10:00 AM- 10:15 AM

Integrating Patient Data and hiPSC Microglia to Model Alzheimer’s Disease for Drug Discovery

Presenter: Henrik Renner, Senior Research Scientist, iPSC Drug Discovery
Date and Time: Thursday, 10 September, 2026, 11:50 AM - 12:05 PM

Human iPSC Models for Safer Drug Discovery Through Predictive Teratogenicity Assessment

Presenter: Bastian Zimmer, VP iPSC Drug Discovery
Date and Time: Friday, 11 September, 2026, 09:45 AM - 10:00 AM

Poster Presentations

Modeling Human Heart Atlas-Derived Disease Mechanisms in iPSC-Based Cardiac Systems (Abstract No. P057)

Presenter: Kinga Wrona, Research Associate, iPSC Drug Discovery
Date and Time: Wednesday, 09 September, 2026, 05:30 PM - 06:30 PM

Scalable 3D Closed Stirred-Tank Reactor Enabling Multi-Lineage Differentiation for Cell Therapy (Abstract No. P061)

Presenter: Thomas Aleyt, Senior Research Assistant Cell Therapy, iPSC Cell Therapy
Date and Time: Wednesday, 09 September, 2026, 05:30 PM - 06:30 PM

GMP iPSC Derived CAR Macrophages with Immune Shielding for Off the Shelf Treatment of Fibrosis (Abstract No. P066)

Presenter: Elisabeth Derksen, Research Assistant, iPSC Cell Therapy
Date and Time: Wednesday, 09 September, 2026, 04:30 PM - 05:30 PM

Off-The-Shelf Immune-Shielded iPSC-Derived Car γδ T Cells as Novel Cell Therapy to Treat Hepatocellular Carcinoma (Abstract No. P070)

Presenter: Judith Hartmann, Senior Research Assistant, iPSC Cell Therapy
Date and Time: Wednesday, 09 September, 2026, 04:30 PM - 05:30 PM

Arrange a Meeting with Us

E.iPSC Drug Discovery Platform Lab Equipment

iPSC Drug Discovery

The industry-leading human iPSC-based drug screening platform which can model diseases in more than 15 cell types. Patient-derived cell-based assays and an enhanced molecular understanding of disease phenotypes are crucial to improving the accuracy of this disease modelling

Learn more
Two scientists working on induced pluripotent stem cell therapy research

Cell Therapy - iPSC-based Programs and Integrated CDMO Solutions

Accelerate scalable cell therapy development through Evotec's industrialized iPSC platform and integrated CDMO capabilities, supporting programs from concept to clinic.

Learn more